Found: 6
Select item for more details and to access through your institution.
Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Liver Toxicity of Antiretroviral Combinations Including Fosamprenavir Plus Ritonavir 1400/100 mg Once Daily in HIV/Hepatitis C Virus-Coinfected Patients.
- Published in:
- AIDS Patient Care & STDs, 2011, v. 25, n. 7, p. 395, doi. 10.1089/apc.2011.0109
- By:
- Publication type:
- Article
Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reappraisal of the outcome of healthcare-associated and community-acquired bacteramia: a prospective cohort study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Progression of liver stiffness predicts clinical events in HIV/HCV-coinfected patients with compensated cirrhosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article